Activation of the p53 pathway by small-molecule-induced MDM2 and MDMX dimerization
Open Access
- 28 June 2012
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences of the United States of America
- Vol. 109 (29), 11788-11793
- https://doi.org/10.1073/pnas.1203789109
Abstract
Activation of p53 tumor suppressor by antagonizing its negative regulator murine double minute (MDM)2 has been considered an attractive strategy for cancer therapy and several classes of p53-MDM2 binding inhibitors have been developed. However, these compounds do not inhibit the p53-MDMX interaction, and their effectiveness can be compromised in tumors overexpressing MDMX. Here, we identify small molecules that potently block p53 binding with both MDM2 and MDMX by inhibitor-driven homo- and/or heterodimerization of MDM2 and MDMX proteins. Structural studies revealed that the inhibitors bind into and occlude the p53 pockets of MDM2 and MDMX by inducing the formation of dimeric protein complexes kept together by a dimeric small-molecule core. This mode of action effectively stabilized p53 and activated p53 signaling in cancer cells, leading to cell cycle arrest and apoptosis. Dual MDM2/MDMX antagonists restored p53 apoptotic activity in the presence of high levels of MDMX and may offer a more effective therapeutic modality for MDMX-overexpressing cancers.Keywords
This publication has 38 references indexed in Scilit:
- Levels of HdmX Expression Dictate the Sensitivity of Normal and Transformed Cells to Nutlin-3Cancer Research, 2006
- Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: Implications for therapyProceedings of the National Academy of Sciences of the United States of America, 2006
- Benzodiazepinedione inhibitors of the Hdm2:p53 complex suppress human tumor cell proliferation in vitro and sensitize tumors to doxorubicin in vivoMolecular Cancer Therapeutics, 2006
- p53 Activation by Small Molecules: Application in OncologyJournal of Medicinal Chemistry, 2005
- The p53 pathway: positive and negative feedback loopsOncogene, 2005
- Mdmx as an essential regulator of p53 activityBiochemical and Biophysical Research Communications, 2005
- In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2Science, 2004
- DNA Damage-induced MDMX Degradation Is Mediated by MDM2Journal of Biological Chemistry, 2003
- Structure of the MDM2 Oncoprotein Bound to the p53 Tumor Suppressor Transactivation DomainScience, 1996
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992